139 related articles for article (PubMed ID: 15577677)
1. Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile.
Wheeler DT; Tai LH; Bratthauer GL; Waldner DL; Tavassoli FA
Am J Surg Pathol; 2004 Dec; 28(12):1587-93. PubMed ID: 15577677
[TBL] [Abstract][Full Text] [Related]
2. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.
Bratthauer GL; Moinfar F; Stamatakos MD; Mezzetti TP; Shekitka KM; Man YG; Tavassoli FA
Hum Pathol; 2002 Jun; 33(6):620-7. PubMed ID: 12152161
[TBL] [Abstract][Full Text] [Related]
3. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Esposito NN; Chivukula M; Dabbs DJ
Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
[TBL] [Abstract][Full Text] [Related]
4. [Tubulolobular carcinoma of breast: a clinicopathologic study of 8 cases].
Shi J; Liang ZY; Meng ZL; Luo YF; Cao JL; Yang CM; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):681-5. PubMed ID: 23302310
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of pure tubular and tubulolobular carcinoma of the breast.
Green I; McCormick B; Cranor M; Rosen PP
Am J Surg Pathol; 1997 Jun; 21(6):653-7. PubMed ID: 9199642
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.
Kuroda H; Tamaru J; Takeuchi I; Ohnisi K; Sakamoto G; Adachi A; Kaneko K; Itoyama S
Virchows Arch; 2006 Apr; 448(4):500-5. PubMed ID: 16538444
[TBL] [Abstract][Full Text] [Related]
7. Tubulolobular carcinoma of the male breast.
Stelow EB; Niehans GA; Batts KP
Am J Surg Pathol; 2005 Jul; 29(7):980. PubMed ID: 15958867
[No Abstract] [Full Text] [Related]
8. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry applied to the differential diagnosis between ductal and lobular carcinoma of the breast.
de Deus Moura R; Wludarski SC; Carvalho FM; Bacchi CE
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):1-12. PubMed ID: 22595945
[TBL] [Abstract][Full Text] [Related]
10. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
Ma YH; Wang K; Li L; Lu ZH; Chen J
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
13. [Invasive breast lobular carcinoma with extracellular mucin: a clinicopathological analysis].
Lyu H; Fu LM; Tu XY; Lu HF; Shui RH; Cheng YF; Li XQ; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):779-783. PubMed ID: 31594042
[No Abstract] [Full Text] [Related]
14. [Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].
Yang GZ; Zhang XL; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):741-4. PubMed ID: 22336156
[TBL] [Abstract][Full Text] [Related]
15. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Bratthauer GL; Wheeler DT; Tavassoli FA
Mod Pathol; 2008 Aug; 21(8):1058; author reply 1058-9. PubMed ID: 18654593
[No Abstract] [Full Text] [Related]
16. Sentinel Lymph Nodes in Classic Invasive Lobular Carcinoma of the Breast: Cytokeratin Immunostain Ensures Detection, and Precise Determination of Extent, of Involvement.
Patel A; D'Alfonso T; Cheng E; Hoda SA
Am J Surg Pathol; 2017 Nov; 41(11):1499-1505. PubMed ID: 28877063
[TBL] [Abstract][Full Text] [Related]
17. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
Brinck U; Jacobs S; Neuss M; Tory K; Rath W; Kulle B; Füzesi L
Anticancer Res; 2004; 24(4):2237-42. PubMed ID: 15330167
[TBL] [Abstract][Full Text] [Related]
18. The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.
Suryadevara A; Paruchuri LP; Banisaeed N; Dunnington G; Rao KA
World J Surg Oncol; 2010 Jun; 8():51. PubMed ID: 20565965
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
20. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
Goldstein NS
Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]